ReVision Implant has secured new funding to advance clinical development of its brain-computer interface technology designed to help restore vision in people with severe blindness.
ReVision Implant, a Belgian neurotechnology
company developing a cortical visual prosthesis for people with severe
blindness, has secured €4 million in an oversubscribed funding round backed by
private investors.
The round included participation from existing
The bionic eye: ReVision Implant lands €4M for a vision device that feeds directly into your brain — TFN
Manchester Spinout Imperagen Raises £5M in Seed Funding to Deploy Quantum Physics, AI Modelling and Automated Labs for Enzyme Engineering
ABILITY Neurotech Receives IMDD Approval to Start Clinical Trial for Chronic Implantation of Brain-Computer Interface in ALS Patients
Manchester Techbio Spin-Out Imperagen Raises £5 Million (6.7 Million USD) Seed Round to Scale Closed-Loop Quantum Biocatalysis Platform - Quantum Computing Report
Belgian neurotech startup ReVision Implant has raised €4M in an oversubscribed round from private investors.
The results are astounding and a major advance, say surgeons involved in international research using the pioneering technology.
Neurosoft Bioelectronics develops minimally invasive brain-computer interface technology designed to improve neural data…
Sight of 84% of people with form of age-related macular degeneration restored after being fitted with device
Imperial College spinout Neubond raised £1.5M in seed funding led by Waseda University Ventures to commercialize its…
Jeff Bezos commits nearly $100M to Flourish, which raised $500M at a $2.5B valuation to build brain-inspired AI that cuts energy…
